A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis
Identification
- Clé publique
- radar:r-b1124e532cd3733b5ba9578ff074ab7c
- Auteurs
- Arduino Aleksander Mangoni · Michael David Wiese · Richard John Woodman · Salvatore Sotgia · Angelo Zinellu · Ciriaco Carru · Julie-Ann Hulin · Ernst Michael Shanahan · Sara Tommasi
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-13T12:42:57.722431+00:00
- Dernière observation des métadonnées
- 2026-11-13T12:42:57.722431+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Flinders University · SA Health · University of South Australia · University of Sassari · Azienda Ospedaliero Universitaria di Sassari · Flinders Medical Centre
Pays d’affiliation déclarés
AU · IT
Résumé documentaire — langue originale
Introduction Observational studies have shown that methotrexate, a conventional synthetic disease-modifying antirheumatic drug (csDMARD), is associated with lower arterial blood pressure (BP) and may reduce cardiovascular risk in rheumatoid arthritis (RA). However, it remains unclear whether a cause-and-effect relationship exists between the use of methotrexate and blood pressure reduction.Patients and methods We conducted a controlled comparative study of treatment-naïve newly diagnosed RA patients commenced on subcutaneous methotrexate (Group 1, n = 31, age 57 ± 15 years, 65% females, Disease Activity Score-28 – C-reactive protein, DAS28-CRP = 4.7 ± 1.2) or the DMARD comparator sulfasalazine (Group 2, n = 31, 54 ± 17 years, 61% females, DAS28-CRP = 5.0 ± 0.8). Clinic systolic (SBP, primary study endpoint) and diastolic BP (DBP) and augmentation index (AIx, a marker of arterial stiffness) were measured at baseline and after one and six months of treatment (ClinicalTrials.gov: NCT03254589).Results After six months, compared to Group 2, Group 1 patients had significantly lower SBP (−7.4 mmHg, 95% CI −14.0 to −0.8, p = 0.03). By contrast, there were no significant between-group differences in DBP (p = 0.18), AIx (p = 0.85), or DAS28-CRP (p = 0.16). A significant effect of single nucleotide polymorphisms (SNPs) rs1801133 (methyl tetrahydrofolate reductase) and rs2231142 (ATP-binding cassette subfamily G member 2) on BP changes during methotrexate treatment was observed.Conclusions This is the first comparative study showing that methotrexate significantly reduces SBP in RA. This effect did not coincide with significant changes in arterial stiffness or disease activity. Further research is warranted to investigate the mechanisms underpinning the SBP-lowering effects of methotrexate, the role of specific SNPs, and whether such effects may account for reduced cardiovascular risk in patients with RA.
Identifiants
- OPENALEX
- https://openalex.org/W4412807195
- DOI
- 10.1080/07853890.2025.2539311
- PMID
- https://pubmed.ncbi.nlm.nih.gov/40742006
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12315184
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- Informa
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. (2025). A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. https://doi.org/10.1080/07853890.2025.2539311
- Chicago
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
- ISO 690
- Arduino Aleksander Mangoni; Michael David Wiese; Richard John Woodman; Salvatore Sotgia; Angelo Zinellu; Ciriaco Carru; Julie-Ann Hulin; Ernst Michael Shanahan; Sara Tommasi. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. 2025. https://doi.org/10.1080/07853890.2025.2539311
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. A controlled comparative study of the effects of methotrexate and pharmacogenetic factors on arterial blood pressure and arterial stiffness in patients with rheumatoid arthritis. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-b1124e532cd3733b5ba9578ff074ab7c/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.1080/07853890.2025.2539311
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.